# US 2009/0269786 A1 · RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0269786 A1
- Document ID: US20090269786A1
- Status: Published application
- Kind: A1
- Application number: 12/430,716
- Filed: 2009-04-27
- Published: 2009-10-29
- Earliest claimed: 2008-04-25
- Assignees: The Board of Trustees of the University of Illinois
- Inventors: David R. Pepperberg; Helene A. Gussin; Fadi T. Khasawneh; An Xie; Haohua Qian; Guy C. Le Breton
- Web page: https://patentgrep.com/patent/US20090269786A1

## CPC

- G01N 33/9426: {GABA, i.e. gamma-amino-butyrate}
- C07K 16/286: {against neuromediator receptors, e.g. serotonin receptor, dopamine receptor}
- C07K 2317/34: Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This invention provides antibodies immunologically specific for ρ1-GABAC receptor protein. The invention also provides methods of making and methods of using said antibodies and kits containing the antibodies.

## Claims

### Claim 1

An antibody that specifically binds to ρ1-GABAC protein.

### Claim 2 (depends on 1)

An antibody of claim 1 comprised in a polyclonal antisera.

### Claim 3 (depends on 1)

An antibody of claim 1 that is a monoclonal antibody.

### Claim 4 (depends on 1)

An antibody of claim 1 that specifically binds to an epitope from the amino acid sequence identified by SEQ ID NO: 1.

### Claim 5 (depends on 1)

An antibody of claim 1 raised by immunizing an animal with a peptide having the amino acid sequence is identified by SEQ ID NO: 1.

### Claim 6 (depends on 1)

An antibody of claim 1 wherein the ρ1-GABAC protein is expressed in retinal cells.

### Claim 7 (depends on 1)

A method for detecting ρ1-GABAC protein comprising the steps of contacting a sample comprising ρ1-GABAC protein with an antibody of claim 1 and detecting binding of the antibody with the protein.

### Claim 8 (depends on 7)

A method of claim 7, wherein the ρ1-GABAC protein is expressed in retinal cells.

### Claim 9 (depends on 7)

A method of claim 7, wherein the ρ1-GABAC protein is detected in a tissue sample.

### Claim 10 (depends on 9)

A method of claim 9, wherein the ρ1-GABAC protein is detected by in situ immunohistochemistry.

### Claim 11 (depends on 7)

A method of claim 7, wherein the ρ1-GABAC protein is detected by Western blot analysis.

### Claim 12 (depends on 1)

A method for detecting expression of ρ1-GABAC protein comprising the steps of contacting ρ1-GABAC protein with an antibody of claim 1 and detecting binding of the antibody with the protein.

### Claim 13 (depends on 12)

A method of claim 12, wherein the ρ1-GABAC protein is expressed in retinal cells.

### Claim 14 (depends on 12)

A method of claim 12, wherein the ρ1-GABAC protein is detected in a tissue sample.

### Claim 15 (depends on 14)

A method of claim 14, wherein the ρ1-GABAC protein is detected by in situ immunohistochemistry.

### Claim 16 (depends on 12)

A method of claim 12, wherein the ρ1-GABAC protein is detected by Western blot analysis.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A method according to any of claims 1 through 16, wherein the ρ1-GABAC protein is human ρ1-GABAC protein.

### Claim 18 (depends on 1)

A kit comprising a preparation of an antibody according to claim 1 and instructions.

### Claim 19 (depends on 18)

A kit according to claim 18, further comprising reagents for performing an immunological assay.

### Claim 20 (depends on 18, 19)

A kit according to claims 18 or 19, wherein the antibody is immunologically specific for human ρ1-GABAC protein.
